Current Opinion in Ophthalmology was launched in 1990. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of Ophthalmology is divided into nine sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.
Section Editors
Robert C. Sergott
Robert C. Sergott, MD, is Co-Director of the neuro-ophthalmology service and Attending Surgeon at Wills Eye Hospital, Philadelphia, USA. He is also Professor of ophthalmology, neurology, and neurosurgery at Thomas Jefferson University. He has authored over 200 articles in peer-reviewed journals and lectured at many national and international meetings. He has been the recipient of grant support from the National Eye Institute, National Institutes of Health, Neurology Division, and the National Multiple Sclerosis Society. In 1996, chairmen of academic ophthalmology departments in the USA elected him one of the 100 best ophthalmologists in America in a vote. He has been involved with clinical and research tele-ophthalmology for the last 10 years, concentrating upon thyroid eye disease, multiple sclerosis and optic neuritis, and ischemic optic neuropathy.
Russell W. Read
Dr Read graduated magna cum laude in 1994 from the University of Alabama School of Medicine, USA. Dr Read completed a residency in ophthalmology at the University of Washington, Seattle and dual fellowships at the Doheny Eye Institute/University of Southern California in Uveitis/Ocular Inflammatory Diseases and Ophthalmic Pathology.
Dr Read joined the faculty of the UAB Department of Ophthalmology in August 2000 where he is now an Associate Professor of Ophthalmology and Pathology. Dr Read is actively involved in the clinical care of patients with uveitis and ocular inflammatory diseases; is funded to perform basic research on the role of complement in ocular inflammatory disease and macular degeneration; and serves as the residency program director for ophthalmology.
Dr Read serves as the Executive Secretary of the American Uveitis Society.
